Contributors |
|
xi | |
Preface |
|
xvii | |
Acknowledgment |
|
xix | |
|
|
|
1 The Theory of Obesity and Epidemiology |
|
|
3 | (6) |
|
|
|
|
9 | (2) |
|
|
|
3 Obesity Metabolism and Pathophysiology |
|
|
11 | (8) |
|
|
4 Microbiome Theory of Obesity |
|
|
19 | (4) |
|
|
5 Hormones of Obesity Care: PYY, Ghrelin, GLP-1, and GIP |
|
|
23 | (3) |
|
|
6 Economics of Bariatric Surgery |
|
|
26 | (2) |
|
|
|
28 | (4) |
|
|
|
32 | (5) |
|
|
|
Section 2 Medical Treatment |
|
|
|
9 Lifestyle: Nutrition, Exercise, and Sleep |
|
|
37 | (3) |
|
|
|
10 Pharmacology: Types, Efficacy, Long-Term Outcomes, and Postoperative Assistance |
|
|
40 | (3) |
|
|
11 Medication Complications |
|
|
43 | (4) |
|
|
12 Preoperative Psychiatry |
|
|
47 | (6) |
|
|
|
|
|
|
|
|
53 | (9) |
|
|
|
|
|
62 | (4) |
|
|
|
15 Gastric Aspiration as a Bariatric Procedure |
|
|
66 | (3) |
|
|
|
69 | (6) |
|
|
|
|
17 Indications for Surgical Management of Obesity: Metabolic and Bariatric Surgery Examination and Board Review |
|
|
75 | (4) |
|
|
|
18 Bariatric Surgery in Pediatric Patients |
|
|
79 | (4) |
|
|
19 Laparoscopic Sleeve Gastrectomy |
|
|
83 | (2) |
|
|
|
20 Laparoscopic Roux-En-Y Gastric Bypass |
|
|
85 | (4) |
|
|
|
21 Biliopancreatic Diversion with Duodenal Switch |
|
|
89 | (4) |
|
|
|
22 Laparoscopic Adjustable Gastric Band |
|
|
93 | (5) |
|
|
|
23 One Anastomosis Gastric Bypass (OAGB)/Mini Gastric Bypass (MGB) |
|
|
98 | (3) |
|
|
24 Single Anastomosis Duodenoileostomy and Sleeve Gastrectomy |
|
|
101 | (8) |
|
|
25.1 Adjustable Gastric Band |
|
|
109 | (6) |
|
|
|
|
115 | (3) |
|
|
|
|
118 | (6) |
|
|
|
|
124 | (7) |
|
|
|
Section 5 Outcomes Short-Term |
|
|
|
26 Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Versus Biliopancreatic Diversion with Duodenal Switch |
|
|
131 | (7) |
|
|
|
27 Conventional Versus MGB/OAGB |
|
|
138 | (2) |
|
|
|
28 Single-Anastomosis Duodeno-Ileal Bypass (SADI) |
|
|
140 | (7) |
|
|
Section 6 Preoperative Preparation |
|
|
|
29 Management and Prehabilitation of Bariatric Patients with Cardiac Disease |
|
|
147 | (3) |
|
|
30 Pulmonary Optimization in Bariatric Surgery |
|
|
150 | (3) |
|
|
|
|
153 | (4) |
|
|
|
157 | (4) |
|
|
|
161 | (3) |
|
|
34 Anesthesia Considerations |
|
|
164 | (4) |
|
|
|
|
|
35 Psychiatric Stability of Axis I and Axis II Disorders |
|
|
168 | (5) |
|
|
Section 7 Outcomes-Medical |
|
|
|
|
173 | (3) |
|
|
|
37 Diabetes Summit: BMI 30 to |
|
|
176 | (4) |
|
|
|
|
180 | (4) |
|
|
39 The Impact of Metabolic and Bariatric Surgery on the Risk and Outcomes of Malignancies |
|
|
184 | (5) |
|
|
|
40 Weight Loss---Long Term |
|
|
189 | (3) |
|
|
|
41 Obstructive Sleep Apnea |
|
|
192 | (3) |
|
|
|
|
195 | (4) |
|
|
|
|
|
|
199 | (5) |
|
|
|
|
204 | (3) |
|
|
|
207 | (3) |
|
|
|
210 | (3) |
|
|
|
|
213 | (6) |
|
|
48 Marginal Ulcer and Gastrogastric Fistula |
|
|
219 | (3) |
|
|
|
|
222 | (13) |
|
|
50 Venous Thromboembolic Events (DVT, PE, Splenic Vein Thrombosis) |
|
|
235 | (3) |
|
|
51 Nausea, Vomiting, and Diarrhea after Bariatric Surgery |
|
|
238 | (4) |
|
|
|
52 Gallstones and Accessing the CBD |
|
|
242 | (3) |
|
|
|
|
53 SBO/Intussusception after Gastric Bypass Surgery |
|
|
245 | (4) |
|
|
|
|
249 | (2) |
|
|
|
55 Weight Regain after Bariatric Surgery |
|
|
251 | (2) |
|
|
56 Psychiatric Complications of Bariatric Surgery |
|
|
253 | (2) |
|
|
57 Post-Bariatric Hypoglycemia |
|
|
255 | (7) |
|
|
58 Mortality Following Bariatric Surgery |
|
|
262 | (9) |
|
|
|
|
|
|
271 | (4) |
|
|
|
|
275 | (6) |
|
|
|
61 Exercise after Bariatric Surgery |
|
|
281 | (3) |
|
|
62 Body Contouring Surgery |
|
|
284 | (3) |
|
|
|
|
|
|
63 Abdominal Wall Hernias |
|
|
287 | (6) |
|
|
|
64 Bariatric Surgery and Transplant |
|
|
293 | (4) |
|
|
Index |
|
297 | |